COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

BACKGROUND: The effects that therapies for inflammatory bowel disease (IBD) have on immune responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to determine whether COVID-19 vaccine-induced antibody responses were altered in patients with IBD on commonly used immunosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, James L, Kennedy, Nicholas A, Ibraheim, Hajir, Anandabaskaran, Sulak, Saifuddin, Aamir, Castro Seoane, Rocio, Liu, Zhigang, Nice, Rachel, Bewshea, Claire, D'Mello, Andrea, Constable, Laura, Jones, Gareth R, Balarajah, Sharmili, Fiorentino, Francesca, Sebastian, Shaji, Irving, Peter M, Hicks, Lucy C, Williams, Horace R T, Kent, Alexandra J, Linger, Rachel, Parkes, Miles, Kok, Klaartje, Patel, Kamal V, Teare, Julian P, Altmann, Daniel M, Boyton, Rosemary J, Goodhand, James R, Hart, Ailsa L, Lees, Charlie W, Ahmad, Tariq, Powell, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813209/
https://www.ncbi.nlm.nih.gov/pubmed/35123676
http://dx.doi.org/10.1016/S2468-1253(22)00005-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813209/
https://www.ncbi.nlm.nih.gov/pubmed/35123676
http://dx.doi.org/10.1016/S2468-1253(22)00005-X

Ejemplares similares